122 related articles for article (PubMed ID: 35347005)
1. The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity Score.
Samhouri Y; Mustafa Ali MK; Khan C; Wegner R; Lee ST; Lister J
Anticancer Res; 2022 Apr; 42(4):1867-1877. PubMed ID: 35347005
[TBL] [Abstract][Full Text] [Related]
2. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
Olszewski AJ; Shrestha R; Castillo JJ
J Clin Oncol; 2015 Feb; 33(6):625-33. PubMed ID: 25584010
[TBL] [Abstract][Full Text] [Related]
3. Treatment Selection and Survival in Patients with Gray Zone Lymphoma: A Comprehensive Population-Based Analysis.
Samhouri Y; Jayakrishnan TT; Alnimer L; Bakalov V; Wegner RE; Khan C; Fazal S; Lister J
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):245-253. PubMed ID: 37023222
[TBL] [Abstract][Full Text] [Related]
4. Consolidative Autologous Stem Cell Transplantation Versus Whole Brain Radiation in PCNSL; a Nationwide Analysis.
Samhouri Y; Mustafa Ali MK; Law J; Khan C; Wegner R; Lee ST; Lister J
Clin Lymphoma Myeloma Leuk; 2022 Oct; 22(10):735-743. PubMed ID: 35705438
[TBL] [Abstract][Full Text] [Related]
5. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis.
Prica A; Chan K; Cheung M
Neuro Oncol; 2014 Oct; 16(10):1384-91. PubMed ID: 24799455
[TBL] [Abstract][Full Text] [Related]
7. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
[TBL] [Abstract][Full Text] [Related]
8. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
9. Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.
Abdelsalam M; El-Husseiny G; Akhtar S; Khafaga Y; Al-Shabana M; AlHusaini H; El Weshi A; Rahal M; Maghfoor I
Hematol Oncol Stem Cell Ther; 2010; 3(3):128-34. PubMed ID: 20890070
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
[TBL] [Abstract][Full Text] [Related]
11. Stage III follicular lymphoma: long-term follow-up and patterns of failure.
Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780
[TBL] [Abstract][Full Text] [Related]
12. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis.
Prica A; Chan K; Cheung MC
Br J Haematol; 2012 Sep; 158(5):600-7. PubMed ID: 22734565
[TBL] [Abstract][Full Text] [Related]
13. The role of additional radiotherapy for primary central nervous system lymphoma.
Zacher J; Kasenda B; Engert A; Skoetz N
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009211. PubMed ID: 24931518
[TBL] [Abstract][Full Text] [Related]
14. Outcome and Prognostic Factors of Primary Central Nervous System Lymphoma in Southern Thailand.
Sopittapan T; Tunthanathip T; Kaewborisutsakul A
Asian J Neurosurg; 2020; 15(3):560-565. PubMed ID: 33145207
[TBL] [Abstract][Full Text] [Related]
15. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
17. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
18. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
19. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
[TBL] [Abstract][Full Text] [Related]
20. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck.
Kim GE; Lee SW; Chang SK; Park HC; Pyo HR; Kim JH; Moon SR; Lee HS; Choi EC; Kim KM
Radiother Oncol; 2001 Dec; 61(3):261-9. PubMed ID: 11730995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
